{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:31:47Z","timestamp":1787758307925,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.4103\/jispcd.jispcd_161_22","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:11:32Z","timestamp":1667124692000},"page":"500-505","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["C3 Targeted Complement Therapy for Chronic Periodontitis \u2013 A Scoping Review"],"prefix":"10.4103","volume":"12","author":[{"given":"Rupali","family":"Agnihotri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/prd.12297","article-title":"The role of inflammation and genetics in periodontal disease","volume":"83","author":"Loos","year":"2020","journal-title":"Periodontol 2000"},{"key":"R2-3-20240828","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-319-18603-0_4","article-title":"Complement involvement in periodontitis: Molecular mechanisms and rational therapeutic approaches","volume":"865","author":"Hajishengallis","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"R3-3-20240828","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.imbio.2012.07.007","article-title":"Complement and dysbiosis in periodontal disease","volume":"217","author":"Hajishengallis","year":"2012","journal-title":"Immunobiology"},{"key":"R4-3-20240828","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrmicro2873","article-title":"The keystone-pathogen hypothesis","volume":"10","author":"Hajishengallis","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"R5-3-20240828","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s40496-020-00249-3","article-title":"Porphyromonas gingivalis: Immune subversion activities and role in periodontal dysbiosis","volume":"7","author":"Hajishengallis","year":"2020","journal-title":"Curr Oral Health Rep"},{"key":"R6-3-20240828","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2019.00406","article-title":"Complement-dependent mechanisms and interventions in periodontal disease","volume":"10","author":"Hajishengallis","year":"2019","journal-title":"Front Immunol"},{"key":"R7-3-20240828","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.4049\/jimmunol.1400569","article-title":"Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis","volume":"192","author":"Maekawa","year":"2014","journal-title":"J Immunol"},{"key":"R8-3-20240828","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/jcpe.12507","article-title":"Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3","volume":"43","author":"Maekawa","year":"2016","journal-title":"J Clin Periodontol"},{"key":"R9-3-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.omtm.2017.08.001","article-title":"Safety and efficacy of the complement inhibitor AMY-101 in a natural model of periodontitis in non-human primates","volume":"6","author":"Kajikawa","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R10-3-20240828","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1021\/acs.jproteome.8b00263","article-title":"Gingival exudatome dynamics implicate inhibition of the alternative complement pathway in the protective action of the C3 inhibitor cp40 in nonhuman primate periodontitis","volume":"17","author":"Bostanci","year":"2018","journal-title":"J Proteome Res"},{"key":"R11-3-20240828","doi-asserted-by":"crossref","first-page":"e152973","DOI":"10.1172\/JCI152973","article-title":"Forsyth Institute Center for Clinical and Translational Research staff, Lambris JD, Mastellos DC, Yancopoulou D. Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammation","volume":"131","author":"Hasturk","year":"2021","journal-title":"J Clin Invest"},{"key":"R12-3-20240828","doi-asserted-by":"crossref","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin Immunol"},{"key":"R13-3-20240828","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: A C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"R14-3-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jre.12788","article-title":"Complement split product C3C in saliva as biomarker for periodontitis and response to periodontal treatment","volume":"56","author":"Grande","year":"2021","journal-title":"J Periodontal Res"},{"key":"R15-3-20240828","doi-asserted-by":"crossref","first-page":"eabo2341","DOI":"10.1126\/sciadv.abo2341","article-title":"Complement C3 inhibition in severe COVID-19 using compstatin AMY-101","volume":"8","author":"Skendros","year":"2022","journal-title":"Sci Adv"},{"key":"R16-3-20240828","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2249.2009.03972.x","article-title":"Expression and regulation of the NALP3 inflammasome complex in periodontal diseases","volume":"157","author":"Bostanci","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"R17-3-20240828","doi-asserted-by":"crossref","first-page":"599236","DOI":"10.3389\/fmed.2020.599236","article-title":"Complement, a therapeutic target in diabetic kidney disease","volume":"7","author":"Budge","year":"2020","journal-title":"Front Med (Lausanne"}],"container-title":["Journal of International Society of Preventive and Community Dentistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jispcd.JISPCD_161_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:12:16Z","timestamp":1787757136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jispcd.JISPCD_161_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jispcd.jispcd_161_22","relation":{},"ISSN":["2231-0762"],"issn-type":[{"value":"2231-0762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}